These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12914858)

  • 1. [Chemoradiation in pancreatic carcinoma].
    Claude L; Mornex F
    Cancer Radiother; 2003 Aug; 7(4):254-65. PubMed ID: 12914858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation.
    Fujita T
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577725
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment.
    Hudson E; Hurt C; Mort D; Brewster AE; Iqbal N; Joseph G; Crosby TD; Mukherjee S
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):27-35. PubMed ID: 19896352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation.
    Vikram B
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577724
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemoradiation for pancreatic cancer: few good data, much debate.
    Twombly R
    J Natl Cancer Inst; 2008 Dec; 100(23):1670-1. PubMed ID: 19033566
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 8. The recent past and future of adjuvant therapy for pancreatic cancer.
    Yeo CJ
    Ann Surg Oncol; 2003 Jun; 10(5):488-9. PubMed ID: 12794012
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
    Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
    JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
    Regine WF; Winter KA; Abrams R; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Rich TA; Willett CG
    Ann Surg Oncol; 2011 May; 18(5):1319-26. PubMed ID: 21499862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant strategies for pancreatic cancer.
    Ghaneh P; Smith R; Tudor-Smith C; Raraty M; Neoptolemos JP
    Eur J Surg Oncol; 2008 Mar; 34(3):297-305. PubMed ID: 17936564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.
    Landry J; Catalano PJ; Staley C; Harris W; Hoffman J; Talamonti M; Xu N; Cooper H; Benson AB
    J Surg Oncol; 2010 Jun; 101(7):587-92. PubMed ID: 20461765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.
    Krishnan S; Rana V; Janjan NA; Abbruzzese JL; Gould MS; Das P; Delclos ME; Palla S; Guha S; Varadhachary G; Evans DB; Wolff RA; Crane CH
    Cancer; 2006 Dec; 107(11):2589-96. PubMed ID: 17083124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
    Breslin TM; Hess KR; Harbison DB; Jean ME; Cleary KR; Dackiw AP; Wolff RA; Abbruzzese JL; Janjan NA; Crane CH; Vauthey JN; Lee JE; Pisters PW; Evans DB
    Ann Surg Oncol; 2001 Mar; 8(2):123-32. PubMed ID: 11258776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.
    Kornek GV; Pötter R; Selzer E; Schratter A; Ulrich-Pur H; Rogy M; Kraus G; Scheithauer W
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):665-71. PubMed ID: 11172947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
    Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
    J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study.
    Iannitti D; Dipetrillo T; Akerman P; Barnett JM; Maia-Acuna C; Cruff D; Miner T; Martel D; Cioffi W; Remis M; Kennedy T; Safran H
    Am J Clin Oncol; 2005 Dec; 28(6):570-5. PubMed ID: 16317266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.
    Sohal DP; Metz JM; Sun W; Giantonio BJ; Plastaras JP; Ginsberg G; Kochman ML; Teitelbaum UR; Harlacker K; Heitjan DF; Feldman MD; Drebin JA; O'Dwyer PJ
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1485-91. PubMed ID: 23532207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma.
    Reni M; Cereda S; Balzano G; Passoni P; Rognone A; Zerbi A; Nicoletti R; Mazza E; Arcidiacono PG; Di Carlo V; Villa E
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1253-9. PubMed ID: 19381632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.